Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial - Wu, Y L; Lee, J S; Thongprasert, S (Lancet Oncol, 2013)
, et al.